Immatics N.V. (IMTX)

Healthcare · Biotechnology · NASDAQ

Immatics N.V. (IMTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.35B and a free-cash-flow yield of -19.4%. Over the most recent reported fiscal year, revenue declined 69.0%.

Market cap	$1.35B
Trailing P/E	—
FCF yield	-19.4%
Revenue growth (YoY)	-69.0%
EPS growth (YoY)	-1353.3%
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live IMTX data on Nama Insights →